Q1 met expectations, but the guidance downgrade was a surprise
08/05/25 -"Demant’s Q1 results met market expectations. Growth in Hearing Care was counterbalanced by weakness in Hearing Aids. Meanwhile, Diagnostics remained stable. However, profitability fell short of ..."
Pages
58
Language
English
Published on
08/05/25
You may also be interested by these reports :
19/03/26
MedTechs remain a disaster story – held back by a series of never-ending headwinds, like supply chain, interest rates, slowing China, tariffs etc., ...
18/03/26
We have revised our earnings estimates downward due to ongoing business weaknesses and persistent macroeconomic challenges, which continue to weigh ...
18/03/26
While medium-to-long-term targets appear credible – which also reflect in the upside on fundamental valuation metrics (i.e. DCF and NAV), the ...
16/03/26
Amplifon has announced the acquisition of GN Store Nord’s hearing business, marking a shift towards a backward integration strategy, which deviates ...